At 31, I was called in as the CEO of Halo, despite knowing very little about biotech, and we had only three months of cash on hand with no VC dollars invested.

I dropped out of my PhD program in machine learning to join a startup, which was a high-risk decision that ultimately paid off.

I was 23 when I became a founder, transitioning from studying sculpture at the Academy of Fine Arts in Helsinki to the tech industry, which felt unconventional for someone with my background.

I started a couple of startups and then joined Facebook before leaving to start Mystery Science with Doug.

After exiting my first company, I spent time working at startups and venture builders to gain experience and learn from faster-growing companies.

After college, I worked at a biotech firm but felt the slow career progression pushed me to pursue entrepreneurship, especially after a roommate suggested we start a company together.

After quitting my corporate job due to lack of learning, I joined a startup where I learned valuable lessons about what not to do in business.

After being encouraged by founders like Drew Houston and Sam Altman, I applied to Y Combinator, despite my initial hesitation about giving up equity.

I worked as an engineer at Abbott Vascular and a smaller startup, but I felt an urge to start my own company at 24, driven by my past health experiences.